BSE filing, NSE: SANPA. Summary written from the filing by ALFA Finder's alert engine.
Sangal Papers Ltd: key numbers
- Share price
- ₹189.70
- Market cap
- ₹24.80 Cr
- Revenue (annual)
- ₹179.3 Cr
- Net profit (annual)
- ₹2.37 Cr
- P/E (TTM)
- 5.8×Sector 45.0×
- Promoter holding
- 39.48%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sangal Papers Ltd
All →Sangal Papers Board Meeting Date
Sangal Papers Ltd will hold a Board meeting on 14/11/2026 to consider its unaudited quarterly results. The trading window for designated persons stays closed until the outcome is announced.
Sangal Papers Management Change
Sangal Papers intimated the demise of Cost Auditor CMA S.R. Kapur on October 18, 2026. The company will fill the casual vacancy within statutory timelines.
Sangal Papers Other Announcement
Sangal Papers Ltd filed an update regarding the administrative rectification of typographical errors in its Registered Office address on the MCA portal.
Sangal Papers Board Meeting Outcome
Sangal Papers Limited's board approved correcting clerical and typographical errors in its registered office address records. No physical shifting or relocation of the office has occurred.
Sangal Papers Legal & Regulatory
Sangal Papers Limited received a rectification order from the Income Tax Department for A.Y. 2025-2026. The order raises a tax demand of ₹0.15 Crore.
- Value
- ₹0.15 Cr
- From
- Income Tax Department
Sangal Papers Management Change
Sanjal Papers re-appointed Tanmay Sangal and Vinayak Sangal as Non-Executive Non-Independent Directors for 12 months effective September 2026. No financial impact accompanies this routine board compliance filing.
- Execution
- 12 months
Other board meeting date announcements
All →Sanstar Board Meeting Date
Sanstar Ltd has scheduled a board meeting for 5 November 2026 to approve Q2 and H1 FY27 unaudited results. The trading window has been closed since 1 October 2026.
Kilitch Drugs(I) Board Meeting Date
Kilitch Drugs will hold a board meeting on 6 November 2026 to consider unaudited quarterly and half-year results. The trading window stays closed until 48 hours after disclosure.
Foods & Inns Board Meeting Date
Foods and Inns has given prior notice of an audit committee meeting on November 5, 2026, to consider unaudited standalone and consolidated half-yearly results for September 2026. The trading window is closed from October 1 to November 7, 2026.
Hitachi Energy India Board Meeting Date
Hitachi Energy India will hold a board meeting on November 12, 2026 to consider Q2 results. An analyst call is scheduled the same evening.
Euro India Fresh Foods Board Meeting Date
Euro India Fresh Foods has given notice of a board meeting on November 7, 2026, to consider unaudited standalone half-yearly results for September 2026. The trading window stays closed until November 17, 2026.
Axentra Corp Board Meeting Date
Axentra Corp scheduled a board meeting on November 5, 2026 to consider quarterly and half-year results. This advance notice reports no decisions yet.